WASHINGTON(August 22, 2023)- Mifepristone, a key abortion drug, and its limits and uses are set to be argued in 5th Circuit Court of Appeals, and likely to be picked up by the Supreme Court. The FDA currently allows the drug to be taken until 10 weeks into pregnancy, be mailed directly to patients and prescribed by a non-doctor medical professionals.
If you would like more context on the matter, please consider Sonia Suter, The Henry St. George Tucker III Dean’s Research Professor Law; The Kahan Family Research Professor of Law; Founding Director, Health Law Initiative and the George Washington University Law School. Professor Suter is an internationally recognized expert on issues at the intersectional of law, medicine and bioethics, with a particular focus on reproductive rights, emerging reproductive technologies, and ethical and legal issues in genetics. In addition, Professor Suter works on national advisory boards and consults policymakers on issues in the field.
To speak with Professor Sonia Suter, please contact Media Relations Specialist Shannon Mitchell at [email protected].